Pulmonary Embolism and COVID-19

Last updated: May 1, 2021
Sponsor: Uşak University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Venous Thromboembolism

Lung Disease

Deep Vein Thrombosis

Treatment

N/A

Clinical Study ID

NCT04590378
UU-PE001
  • Ages 18-80
  • All Genders

Study Summary

The charts of patients who developed pulmonary embolism in the course of COVID-19 will be evaluated, retrospectively. Clinical features and laboratory data will be analyzed.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • All patients with positive RT-PCR for COVID-19

Exclusion

Exclusion Criteria:

  • All patients with negative RT-PCR for COVID-19

Study Design

Total Participants: 600
Study Start date:
March 01, 2020
Estimated Completion Date:
December 01, 2021

Study Description

Patients with COVID-19 infection will be evaluated retrospectively. Demographic data, clinical and laboratory findings will be recorded. Findings of patients with pulmonary embolism and withour pulmonary embolism will be compared.

Connect with a study center

  • Uşak University

    Usak, 64200
    Turkey

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.